Alopecia Induced by Tumor Necrosis Factor-Alpha Antagonists: Description of 52 Cases and Disproportionality Analysis in a Nationwide Pharmacovigilance Database

    March 2014 in “ Rheumatology ”
    Johana Béné, Guillaume Moulis, Marine Auffret … Sophie Gautier
    Studysummary This study confirms an association between TNF-α antagonist exposure and alopecia, indicating a class effect among the medications examined.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on academic.oup.com →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Alopecia Areata as Another Immune-Mediated Disease Developed in Patients Treated with Tumor Necrosis Factor-Alpha Blocker Agents Journal of the European Academy of Dermatology and Venereology · 2010
    2. Alopecia Areata Following Adalimumab Journal of Cutaneous Medicine and Surgery · 2009
    3. Development of Alopecia Areata Universalis in a Patient Receiving Adalimumab Archives of dermatology · 2006
    4. Alopecia Areata Presenting in Two Kidney-Pancreas Transplant Recipients Taking Cyclosporine Journal of The American Academy of Dermatology · 2005
    5. Recurrence of Alopecia Areata in a Patient Receiving Etanercept Injections Archives of Dermatology · 2005